Last Updated On 3/28/2026 11:34:55 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: Taiho Pharmaceutical |
| Recipient: You |
| Company: Merck Serono |
| Recipient: You |
| Company: Daiichi Sankyo |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: MSD |
| Recipient: You |
| Company: Y-Biologics |
| Recipient: You |
| Company: TopAlliance BioSciences Inc |
| Recipient: You |
| Company: Natera |
| Recipient: You |
| Company: Pierre Fabre |
| Recipient: You |
| Company: Alentis Therapeutics |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: Viracta Therapeutics |
| Recipient: You |
| Company: Dr Reddy |
| Recipient: You |
| Company: HUTCHMED |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Merck Sharp & Dohme |
| Recipient: You |
| Company: Y-biologics |
| Recipient: You |
| Company: Viracta Therapeutics |
| Recipient: You |
| Company: Alentis Therapeutics |
| Recipient: You |
| Company: Pierre Fabre |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Natera |
| Recipient: You |
| Company: Revolution Medicines |
| Recipient: You |
| Company: Merck Serono |
| Recipient: You |
| Company: GSK |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Merck Serono |
| Recipient: You |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Taiho Pharmaceutical |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|